CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 53 enrolled
Drug / intervention
CanCopebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05328362
NCT05328362N/ACompleted
CompareCT.gov

CanCope: Digital Intervention for Coping With Cannabis Craving

Trustees of Dartmouth College·interventional·Posted Apr 14, 2022·Updated Jan 22, 2025

In Brief

A clinical study evaluating CanCope for Cannabis Use. Completed, enrolled 53 participants across 1 site.

Detailed Summary

The CanCope Study is a micro-randomized trial conducted to gather evidence about and compare the effectiveness of a momentary intervention to help young adults cope with cannabis cravings as they attempt to reduce their use.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsCannabis Use
CountriesUnited States
CollaboratorsUniversity of Michigan

Timeline

N/ACompletedFinished
20222023202420252026
First PostedApr 14, 2022
Enrollment StartAug 27, 2021
Primary CompletionDec 16, 2021
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 4.2 years ago

Interventions

CanCopebehavioral

Messages prompted participants to use mindfulness-based or distraction-based coping strategies, or a thank-you message which served as an attention control. If participants reported elevated craving (4 or greater) prior to a decision point, they received either a coping strategy message or a control message. If participants reported craving levels of less than 4 they received a control message.